Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vasilopoulos

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Folia Morphologica|May 21, 2019
An aperture in the sagittal plane of the dorsal wall of the sacrumG Tsoucalas, E Panagouli, A Vasilopoulos, et al.
Hippokratia|October 23, 2014
Insomnia and burnout in Greek NursesSa Kousloglou, Od Mouzas, K Bonotis, et al.
Physical Review. E|September 19, 2023
Two-dimensional dilute Baxter-Wu model: Transition order and universalityA R S Macêdo, A Vasilopoulos, M Akritidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2025
Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinibH Horinouchi, B C Cho, D R Camidge, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Folia Morphologica|May 21, 2019
An aperture in the sagittal plane of the dorsal wall of the sacrumG Tsoucalas, E Panagouli, A Vasilopoulos, et al.
Hippokratia|October 23, 2014
Insomnia and burnout in Greek NursesSa Kousloglou, Od Mouzas, K Bonotis, et al.
Physical Review. E|September 19, 2023
Two-dimensional dilute Baxter-Wu model: Transition order and universalityA R S Macêdo, A Vasilopoulos, M Akritidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2025
Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinibH Horinouchi, B C Cho, D R Camidge, et al.
Pageof 1